InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by MOORE JOHN R, Conseiller Juridique Général. Insider active across 1 companies, notably Edgewise Therapeutics, Inc.. In total, 9 disclosures have been logged. Total volume traded: €77k. The latest transaction was disclosed on 16 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
€26,94014,722 shares@ €1.82990.0010% mcap17.3% of flow
Common Stock
SEC:0001562180-22-005251:0·
€2,7904,093 shares@ €0.68170.0001% mcap1.8% of flow
Common Stock
SEC:0001562180-22-005126:0·
€8,32412,566 shares@ €0.66250.0003% mcap5.3% of flow
Common Stock
SEC:0001562180-22-005053:0·
€27,34015,230 shares@ €1.79520.0010% mcap17.6% of flow
Common Stock
SEC:0001562180-22-004887:0·
€76,77610,800 shares@ €7.10890.0029% mcap49.3% of flow
Common Stock
SEC:0001562180-22-004201:0·
€3,3895,400 shares@ €0.62760.0001% mcap50.0% of flow
Common Stock
SEC:0001562180-22-000645·
€3,3895,400 shares@ €0.62760.0001% mcap2.2% of flow
Common Stock
SEC:0001562180-22-000645:0·
€3,3845,400 shares@ €0.62670.0001% mcap50.0% of flow
Common Stock
SEC:0001562180-21-007920·
€3,3845,400 shares@ €0.62670.0001% mcap2.2% of flow
Common Stock
SEC:0001562180-21-007920:0·
9 of 9 declarations
About MOORE JOHN R
John R. Moore serves as General Counsel at Edgewise Therapeutics, Inc. In this role, he oversees the company's legal affairs and ensures compliance with regulations. Moore plays a crucial role in managing legal risks and protecting the company's interests. His expertise in business law is vital for the success of Edgewise Therapeutics.
